ARID1A and Thrombocytosis: Early Relapse (≤6 months) was primarily driven by higher stage (II–IV), positive peritoneal cytology, thrombocytosis, grade-3 endometrioid histology (G3), deep myometrial invasion, and ARID1A loss, with elevated CA125 providing additional risk.